Inhibikase Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Inhibikase Therapeutics by Wells Fargo & Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $255 | 201 | 1.27 |
2023-09-30 | $323 | 232 | 1.39 |
2023-06-30 | $705 | 196 | 3.60 |